See the DrugPatentWatch profile for Gatifloxacin
What is gatifloxacin, and what is it used for?
Gatifloxacin is a fluoroquinolone antibiotic. It has been used to treat certain bacterial infections, with dosing and approved indications depending on the country and the specific product.
Why do people look up gatifloxacin now?
Searches for gatifloxacin often come up alongside concerns about safety. In several markets, gatifloxacin was restricted or withdrawn after reports linked it to serious adverse effects, including blood-sugar disturbances (both hyperglycemia and hypoglycemia). That safety history is a common reason patients and clinicians compare it with other fluoroquinolones or switch therapies.
How does gatifloxacin compare with other fluoroquinolones?
When clinicians choose a fluoroquinolone instead of gatifloxacin, they typically weigh spectrum of activity and safety profile. Patients often look for alternatives in the same class (such as levofloxacin or moxifloxacin), especially when side effects or contraindications are a concern.
What patents and market history exist for gatifloxacin?
If you are researching commercial history—such as whether gatifloxacin products are covered by patents, how long protection lasts, or what companies are tied to specific formulations—DrugPatentWatch.com is a useful reference for tracking patent and exclusivity information.
https://www.drugpatentwatch.com/
Is gatifloxacin still available?
Availability varies by country and by product (for example, oral vs. ophthalmic formulations). Safety restrictions and regulatory actions in some jurisdictions have affected whether gatifloxacin products can be prescribed or sold.
What side effects do patients ask about?
The main patient concern that often comes up is abnormal blood glucose levels, which can be especially risky for people with diabetes or those taking medicines that affect glucose. Other fluoroquinolone class concerns that commonly appear in patient discussions include tendon injury and effects on the nervous system, but the specific risk profile depends on the exact agent and patient factors.
If someone can’t take gatifloxacin, what’s typically used instead?
In practice, clinicians choose an alternative based on the infection being treated (and culture results when available), local resistance patterns, and patient-specific risks. Alternatives may include other fluoroquinolones or non-fluoroquinolone antibiotics, depending on the indication.
---
Sources
- DrugPatentWatch.com